Risk factors, mortality, and timing of ischemic and hemorrhagic stroke with left ventricular assist devices

Journal of Heart and Lung Transplantation

Volumn 36, Issue 6, 2017, Pages 673-683

  Frontera, Jennifer A ^a   Starling, Randall ^b   Cho, Sung Min ^a   Nowacki, Amy S ^b   Uchino, Ken ^a   Hussain, M Shazam ^a   Mountis, Maria ^b   Moazami, Nader ^b  

^a NEW YORK UNIVERSITY   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

hemorrhagic stroke; intracranial hemorrhage; ischemic stroke; Left ventricular assist device; mortality risk factors; stroke

Indexed keywords

ACETYLSALICYLIC ACID; ANTIBIOTIC AGENT; ANTICOAGULANT AGENT; HEPARIN; THROMBOPLASTIN; WARFARIN;

ADULT; AGED; ARTICLE; BACTEREMIA; BLOODSTREAM INFECTION; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CAUSE OF DEATH; CLINICAL ASSESSMENT; CONTINUOUS FLOW LEFT VENTRICULAR ASSIST DEVICE; CONTROLLED STUDY; CORONARY RISK; DEVICE INFECTION; DISEASE ASSOCIATION; DRIVELINE INFECTION; DRUG DOSE TITRATION; FEMALE; GASTROINTESTINAL HEMORRHAGE; HIGH RISK PATIENT; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; HYPERTENSION; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MANAGED CARE; MORTALITY RATE; MORTALITY RISK; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PUMP INFECTION; PUMP THROMBOSIS; RISK ASSESSMENT; RISK FACTOR; THROMBOSIS; TIME TO TREATMENT; TOBACCO USE; URINARY TRACT INFECTION; WOUND INFECTION; ADOLESCENT; ADVERSE DEVICE EFFECT; HEART ASSIST DEVICE; HEART FAILURE; INCIDENCE; MIDDLE AGED; MORTALITY; PROSTHESIS COMPLICATION; SURVIVAL RATE; TRENDS; UNITED STATES; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; BRAIN ISCHEMIA; FEMALE; HEART FAILURE; HEART-ASSIST DEVICES; HUMANS; INCIDENCE; INTRACRANIAL HEMORRHAGES; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PROSTHESIS FAILURE; RISK ASSESSMENT; RISK FACTORS; SURVIVAL RATE; UNITED STATES; YOUNG ADULT;

EID: 85009751197     PISSN: 10532498     EISSN: 15573117     Source Type: Journal    
DOI: 10.1016/j.healun.2016.12.010     Document Type: Article

References (31)

1. 1 Litzler, P.Y., Smail, H., Barbay, V., et al. Is anti-platelet therapy needed in continuous flow left ventricular assist device patients? A single-centre experience. Eur J Cardiothorac Surg 45 (2014), 55–59 discussion 59-60.
2. 2 Cowger, J.A., Romano, M.A., Shah, P., et al. Hemolysis: a harbinger of adverse outcome after left ventricular assist device implant. J Heart Lung Transplant 33 (2014), 35–43.
3. 3 Bashir, J., Legare, J.F., Freed, D.H., Cheung, A., Rao, V., Toma, M., Multicentre Canadian experience with the HeartWare ventricular assist device: concerns about adverse neurological outcomes. Can J Cardiol 30 (2014), 1662–1667.
4. 4 Lalonde, S.D., Alba, A.C., Rigobon, A., et al. Clinical differences between continuous flow ventricular assist devices: a comparison between HeartMate II and HeartWare HVAD. J Card Surg 28 (2013), 604–610.
5. 5 Morgan, J.A., Brewer, R.J., Nemeh, H.W., et al. Stroke while on long-term left ventricular assist device support: incidence, outcome, and predictors. ASAIO J 60 (2014), 284–289.
6. 6 Harvey, L., Holley, C., Roy, S.S., et al. Stroke after left ventricular assist device implantation: outcomes in the continuous-flow era. Ann Thorac Surg 100 (2015), 535–541.
7. 7 Whitson, B.A., Eckman, P., Kamdar, F., et al. Hemolysis, pump thrombus, and neurologic events in continuous-flow left ventricular assist device recipients. Ann Thorac Surg 97 (2014), 2097–2103.
8. 8 Kato, T.S., Schulze, P.C., Yang, J., et al. Pre-operative and post-operative risk factors associated with neurologic complications in patients with advanced heart failure supported by a left ventricular assist device. J Heart Lung Transplant 31 (2012), 1–8.
9. 9 Teuteberg, J.J., Slaughter, M.S., Rogers, J.G., et al. The HVAD left ventricular assist device: risk factors for neurological events and risk mitigation strategies. JACC Heart Fail 3 (2015), 818–828.
10. 10 Kirklin, J.K., Naftel, D.C., Pagani, F.D., et al. Seventh INTERMACS annual report: 15,000 patients and counting. J Heart Lung Transplant 34 (2015), 1495–1504.
11. 11 Aggarwal, A., Gupta, A., Kumar, S., et al. Are blood stream infections associated with an increased risk of hemorrhagic stroke in patients with a left ventricular assist device?. ASAIO J 58 (2012), 509–513.
12. 12 Lindsberg, P.J., Grau, A.J., Inflammation and infections as risk factors for ischemic stroke. Stroke 34 (2003), 2518–2532.
13. 13 Pagani, F.D., Milano, C.A., Tatooles, A.J., et al. HeartWare HVAD for the treatment of patients with advanced heart failure ineligible for cardiac transplantation: results of the ENDURANCE destination therapy trial. J Heart Lung Transplant, 34, 2015, S9.
14. 14 Stulak, J.M., Davis, M.E., Haglund, N., et al. Adverse events in contemporary continuous-flow left ventricular assist devices: a multi-institutional comparison shows significant differences. J Thorac Cardiovasc Surg 151 (2016), 177–189.
15. 15 Trachtenberg, B.H., Cordero-Reyes, A.M., Aldeiri, M., et al. Persistent blood stream infection in patients supported with a continuous-flow left ventricular assist device is associated with an increased risk of cerebrovascular accidents. J Card Fail 21 (2015), 119–125.
16. 16 Larrue, V., von Kummer, R.R., Muller, A., Bluhmki, E., Risk factors for severe hemorrhagic transformation in ischemic stroke patients treated with recombinant tissue plasminogen activator: a secondary analysis of the European-Australasian Acute Stroke Study (ECASS II). Stroke 32 (2001), 438–441.
17. 17 Eckman, P.M., John, R., Bleeding and thrombosis in patients with continuous-flow ventricular assist devices. Circulation 125 (2012), 3038–3047.
18. 18 Slaughter, M.S., Rogers, J.G., Milano, C.A., et al. Advanced heart failure treated with continuous-flow left ventricular assist device. N Engl J Med 361 (2009), 2241–2251.
19. 19 Backes, D., van den Bergh, W.M., van Duijn, A.L., Lahpor, J.R., van Dijk, D., Slooter, A.J., Cerebrovascular complications of left ventricular assist devices. Eur J Cardiothorac Surg 42 (2012), 612–620.
20. 20 Bhimaraj, A., Uribe, C., Suarez, E.E., Physiological impact of continuous flow on end-organ function: clinical implications in the current era of left ventricular assist devices. Methodist Debakey Cardiovasc J 11 (2015), 12–17.
21. 21 Cornwell, W.K. 3rd, Tarumi, T., Aengevaeren, V.L., et al. Effect of pulsatile and nonpulsatile flow on cerebral perfusion in patients with left ventricular assist devices. J Heart Lung Transplant 33 (2014), 1295–1303.
22. 22 John, R., Naka, Y., Park, S.J., et al. Impact of concurrent surgical valve procedures in patients receiving continuous-flow devices. J Thorac Cardiovasc Surg 147 (2014), 581–589 discussion 589.
23. 23 Cantillon, D.J., Tarakji, K.G., Kumbhani, D.J., Smedira, N.G., Starling, R.C., Wilkoff, B.L., Improved survival among ventricular assist device recipients with a concomitant implantable cardioverter-defibrillator. Heart Rhythm 7 (2010), 466–471.
24. 24 Vakil, K., Kazmirczak, F., Sathnur, N., et al. Implantable cardioverter-defibrillator use in patients with left ventricular assist devices: a systematic review and meta-analysis. JACC Heart Fail 4 (2016), 772–779.
25. 25 Morris, A.A., Pekarek, A., Wittersheim, K., et al. Gender differences in the risk of stroke during support with continuous-flow left ventricular assist device. J Heart Lung Transplant 34 (2015), 1570–1577.
26. 26 Bogaev, R.C., Pamboukian, S.V., Moore, S.A., et al. Comparison of outcomes in women versus men using a continuous-flow left ventricular assist device as a bridge to transplantation. J Heart Lung Transplant 30 (2011), 515–522.
27. 27 Boyle, A.J., Jorde, U.P., Sun, B., et al. Pre-operative risk factors of bleeding and stroke during left ventricular assist device support: an analysis of more than 900 HeartMate II outpatients. J Am Coll Cardiol 63 (2014), 880–888.
28. 28 Wilson, T.J., Stetler, W.R. Jr, Al-Holou, W.N., Sullivan, S.E., Fletcher, J.J., Management of intracranial hemorrhage in patients with left ventricular assist devices. J Neurosurg 118 (2013), 1063–1068.
29. 29 Genovese, E.A., Dew, M.A., Teuteberg, J.J., et al. Early adverse events as predictors of 1-year mortality during mechanical circulatory support. J Heart Lung Transplant 29 (2010), 981–988.
30. 30 Holman, W.L., Kormos, R.L., Naftel, D.C., et al. Predictors of death and transplant in patients with a mechanical circulatory support device: a multi-institutional study. J Heart Lung Transplant 28 (2009), 44–50.
31. 31 Pamboukian, S.V., Tallaj, J.A., Brown, R.N., et al. Improvement in 2-year survival for ventricular assist device patients after implementation of an intensive surveillance protocol. J Heart Lung Transplant 30 (2011), 879–887.